Report Detail
Global (United States, European Union and China) Parkinson's Disease Drug Market Research Report 2019-2025
- RnM3369771 |
- 01 May, 2019 |
- Global |
- 122 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Parkinson's Disease Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Parkinson's Disease Drug.
This report studies the global market size of Parkinson's Disease Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Parkinson's Disease Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals
Market Segment by Product Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Parkinson's Disease Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Parkinson's Disease Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Parkinson's Disease Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Parkinson's Disease Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Sinemet-CR
- 1.3.3 Trastal
- 1.3.4 Madopar
- 1.3.5 COMT Inhibitor
- 1.3.6 Other
- 1.4 Market Segment by Application
- 1.4.1 Global Parkinson's Disease Drug Market Share by Application (2019-2025)
- 1.4.2 Under 40 Years Old
- 1.4.3 40-65 Years Old
- 1.4.4 Above 65 Years Old
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Parkinson's Disease Drug Market Size
- 2.1.1 Global Parkinson's Disease Drug Revenue 2014-2025
- 2.1.2 Global Parkinson's Disease Drug Sales 2014-2025
- 2.2 Parkinson's Disease Drug Growth Rate by Regions
- 2.2.1 Global Parkinson's Disease Drug Sales by Regions 2014-2019
- 2.2.2 Global Parkinson's Disease Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Parkinson's Disease Drug Sales by Manufacturers
- 3.1.1 Parkinson's Disease Drug Sales by Manufacturers 2014-2019
- 3.1.2 Parkinson's Disease Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Parkinson's Disease Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Parkinson's Disease Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Parkinson's Disease Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Parkinson's Disease Drug Price by Manufacturers
- 3.4 Key Manufacturers Parkinson's Disease Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Parkinson's Disease Drug Market
- 3.6 Key Manufacturers Parkinson's Disease Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Sinemet-CR Sales and Revenue (2014-2019)
- 4.1.2 Trastal Sales and Revenue (2014-2019)
- 4.1.3 Madopar Sales and Revenue (2014-2019)
- 4.1.4 COMT Inhibitor Sales and Revenue (2014-2019)
- 4.1.5 Other Sales and Revenue (2014-2019)
- 4.2 Global Parkinson's Disease Drug Sales Market Share by Type
- 4.3 Global Parkinson's Disease Drug Revenue Market Share by Type
- 4.4 Parkinson's Disease Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Parkinson's Disease Drug Sales by Application
6 United States
- 6.1 United States Parkinson's Disease Drug Breakdown Data by Company
- 6.2 United States Parkinson's Disease Drug Breakdown Data by Type
- 6.3 United States Parkinson's Disease Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Parkinson's Disease Drug Breakdown Data by Company
- 7.2 European Union Parkinson's Disease Drug Breakdown Data by Type
- 7.3 European Union Parkinson's Disease Drug Breakdown Data by Application
8 China
- 8.1 China Parkinson's Disease Drug Breakdown Data by Company
- 8.2 China Parkinson's Disease Drug Breakdown Data by Type
- 8.3 China Parkinson's Disease Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Parkinson's Disease Drug Breakdown Data by Company
- 9.2 Rest of World Parkinson's Disease Drug Breakdown Data by Type
- 9.3 Rest of World Parkinson's Disease Drug Breakdown Data by Application
- 9.4 Rest of World Parkinson's Disease Drug Breakdown Data by Countries
- 9.4.1 Rest of World Parkinson's Disease Drug Sales by Countries
- 9.4.2 Rest of World Parkinson's Disease Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Merck
- 10.1.1 Merck Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.1.4 Parkinson's Disease Drug Product Introduction
- 10.1.5 Merck Recent Development
- 10.2 Akorn
- 10.2.1 Akorn Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.2.4 Parkinson's Disease Drug Product Introduction
- 10.2.5 Akorn Recent Development
- 10.3 GSK
- 10.3.1 GSK Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.3.4 Parkinson's Disease Drug Product Introduction
- 10.3.5 GSK Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.4.4 Parkinson's Disease Drug Product Introduction
- 10.4.5 Novartis Recent Development
- 10.5 Boehringer Ingelheim
- 10.5.1 Boehringer Ingelheim Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.5.4 Parkinson's Disease Drug Product Introduction
- 10.5.5 Boehringer Ingelheim Recent Development
- 10.6 Teva Pharmaceutical
- 10.6.1 Teva Pharmaceutical Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.6.4 Parkinson's Disease Drug Product Introduction
- 10.6.5 Teva Pharmaceutical Recent Development
- 10.7 Abbvie
- 10.7.1 Abbvie Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.7.4 Parkinson's Disease Drug Product Introduction
- 10.7.5 Abbvie Recent Development
- 10.8 Kyowa Hakko Kirin Pharma
- 10.8.1 Kyowa Hakko Kirin Pharma Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.8.4 Parkinson's Disease Drug Product Introduction
- 10.8.5 Kyowa Hakko Kirin Pharma Recent Development
- 10.9 Astellas Pharma
- 10.9.1 Astellas Pharma Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.9.4 Parkinson's Disease Drug Product Introduction
- 10.9.5 Astellas Pharma Recent Development
- 10.10 Desitin Arzneimittel
- 10.10.1 Desitin Arzneimittel Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Parkinson's Disease Drug
- 10.10.4 Parkinson's Disease Drug Product Introduction
- 10.10.5 Desitin Arzneimittel Recent Development
- 10.11 Endo Pharmaceuticals
- 10.12 F.Hoffmann-La Roche
- 10.13 H.Lundbeck
- 10.14 Valeant
- 10.15 Apokyn
- 10.16 Orion
- 10.17 Stada Arzneimittel
- 10.18 US WorldMeds
- 10.19 Valeant Pharmaceuticals
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Parkinson's Disease Drug Sales Channels
- 11.2.2 Parkinson's Disease Drug Distributors
- 11.3 Parkinson's Disease Drug Customers
12 Market Forecast
- 12.1 Global Parkinson's Disease Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Parkinson's Disease Drug Sales Forecast by Type
- 12.3 Global Parkinson's Disease Drug Sales Forecast by Application
- 12.4 Parkinson's Disease Drug Forecast by Regions
- 12.4.1 Global Parkinson's Disease Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Parkinson's Disease Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Parkinson's Disease Drug . Industry analysis & Market Report on Parkinson's Disease Drug is a syndicated market report, published as Global (United States, European Union and China) Parkinson's Disease Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Parkinson's Disease Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
